Korean J Infect Dis.
1993 Feb;25(1):51-55.
Safety and immunogenicity of a inactivated hemorrhagic fever with renal syndrome vaccine(Hantaan virus vaccine) in children: clinical study of dose regimen
Abstract
- No abstract available.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Identification of G1, G2 and N protein of Hantaan virus in an inactivated HFRS vaccine
- Introduction of Vaccinomics to Develop Personalized Vaccines in Light of Changes in the Usage of Hantaan Virus Vaccine (Hantavax®) in Korea
- Antigenic potency test of hemorrhagic fever with renal syndrome-inactivated vaccine and susceptibility test from challenge of vaccinated animal with Hantaan virus
- Hemorrhagic Fever with Renal Syndrome
- Immunogenicity of hemorrhagic fever with renal syndrome vaccine(hantavax) among Korean children and teenagers
